Table 1.
Age‐group (years) | Men | Women | Total | |||
---|---|---|---|---|---|---|
Cases | Prevalence | Cases | Prevalence | Cases | Prevalence | |
0–14 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
15–19 | 0 | 0.0 | 1 | 10.3 | 1 | 5.0 |
20–24 | 1 | 8.0 | 3 | 24.2 | 4 | 16.0 |
25–29 | 4 | 28.5 | 19 | 142.9 | 23 | 84.1 |
30–34 | 9 | 71.7 | 29 | 250.4 | 38 | 157.4 |
35–39 | 16 | 121.7 | 30 | 234.6 | 46 | 177.3 |
40–44 | 12 | 70.4 | 47 | 285.4 | 59 | 176.0 |
45–49 | 20 | 138.7 | 37 | 257.9 | 57 | 198.2 |
50–54 | 12 | 92.8 | 37 | 277.5 | 49 | 186.6 |
55–59 | 7 | 63.6 | 36 | 290.6 | 43 | 183.8 |
60–64 | 11 | 83.7 | 34 | 211.2 | 45 | 153.9 |
65–69 | 13 | 117.8 | 19 | 126.8 | 32 | 123.0 |
70–74 | 0 | 0.0 | 14 | 111.2 | 14 | 67.0 |
75–79 | 0 | 0.0 | 4 | 39.2 | 4 | 24.7 |
80–84 | 1 | 30.0 | 2 | 28.4 | 3 | 28.9 |
85– | 1 | 41.1 | 1 | 16.2 | 2 | 23.3 |
Crude a | 107 | 56.5 | 313 | 149.3 | 420 | 105.3 |
Age–sex‐adjusted b | 53.9 | 144.8 | 101.8 |
The average incidence of MS for the examined period was 4.44/100,000, 2.44/100,000 for men, and 6.25/100,000 for women, respectively.
Crude prevalence per 100,000 persons.
Standardized prevalence per 100,000 persons (the 2013 European standard population was used as reference population in the direct standardization).